Subsidiary of Hob Biotech Group Corp., Ltd (688656.SH) obtains 2 medical device registration certificates.
Hao Europe Bo (688656.SH) has issued an announcement that its wholly-owned subsidiary, Hunan Hao Europe Bo Biopharmaceutical Co., Ltd., recently...
Hob Biotech Group Corp., Ltd (688656.SH) announced that its wholly-owned subsidiary, Hunan Hob Biotech Group Corp., Ltd Biopharmaceutical Co., Ltd., has recently obtained two medical device registration certificates issued by the Hunan Provincial Drug Administration. The products involved are: "Myositis Autoantibody Spectrum 1 Detection Kit (chemiluminescent magnetic particle method)" and "Anti-Phospholipase A2 Receptor Antibody IgG Detection Kit (chemiluminescent magnetic particle method)".
The acquisition of the above medical device registration certificates further enriches the company's chemiluminescent platform testing menu, which is helpful in enhancing the company's overall market competitiveness. It will have a positive impact and promote the sustainable development of the company and its subsidiaries.
Related Articles

J&T EXPRESS-W(01519): Intends to acquire equity in two non-wholly owned subsidiary companies.

SEACON (02409) subsidiary plans to purchase six ships for $198.6 million.

CIFI HOLD GP (00884): Intends to sell 100% equity in Tianjin and Xin and acquire 50% equity in Ningbo Haishu Xingli.
J&T EXPRESS-W(01519): Intends to acquire equity in two non-wholly owned subsidiary companies.

SEACON (02409) subsidiary plans to purchase six ships for $198.6 million.

CIFI HOLD GP (00884): Intends to sell 100% equity in Tianjin and Xin and acquire 50% equity in Ningbo Haishu Xingli.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


